人血白蛋白

rén xuè bái dàn bái
  • human serum albumin
人血白蛋白人血白蛋白
  1. HPLC法检人血白蛋白中多聚体含量

    HPLC Determination of Polymer in Human Serum Albumin

  2. 5%声振人血白蛋白注射液左心声学造影增强左室内膜分辨的II期多中心临床研究报告

    Enhanced Resolution of Left Ventricular Endocardium by 5 % Sonicated Human Albumin A Multiple Center Stage II Clinical Study

  3. ~(99m)Tc&人血白蛋白聚合大颗粒肺显像剂的研制

    A study on ~ 99mtc - macroaggregated albumin as lung imaging agent

  4. 结果表明标准曲线的线性相关系数r≥0.98,人血白蛋白经3.3倍稀释后无干扰作用。

    The correlation coefficient of standard curve-r is greater or equal to 0.98 , namely , 3.3 folds dilution of human albumin preparation may avoid interference effect .

  5. 采用热稳定性试验,以HPLC法测得的人血白蛋白多聚体含量为考察指标,确定人血白蛋白的贮存有效期。

    Throuth the heat stability test , the valid period of human albumin was calculated by determinating the containing of polymers & aggreates with a HPLC method .

  6. 目的:建立SDS-PAGE结合pH值变化对重组人血白蛋白电泳检测假性结果的分析方法。

    Objective : To establish SDS-PAGE combination with pH change method for analysis of recombinant human serum albumin ( rHSA ) of artificial results by electrophoresis .

  7. 方法采用自身注射前后对照方法,对符合纳入标准的研究对象分别经静脉注入稀释的全氟丙烷人血白蛋白微球注射剂0.01ml/kg,由A和B研究者分别独立进行给药前、后造影效果评判比较。

    Methods Diluted perfluoropropane-albumin microsphere injection was given intravenously to permitted objects at a dose of 0.01 ml / kg . Observers A and observers B evaluated the contrast effect respectively by self-comparison between pre-injection and post-injection .

  8. PLGA微球注射剂的研究进展全氟丙烷人血白蛋白微球注射剂的药物动力学及安全性和耐受性研究

    Biodegradable PLGA microspheres for injectable drug delivery system Study on the Pharmacokinetics of Octafluoropropane-Containing Albumin Microbubbles and Evaluations of Safety and Tolerability

  9. 评价静脉注射人血白蛋白(HSA)对肝硬化腹水患者血浆ATⅡ、VAP、CGRP、ET、肾功能的影响及其作用机制。

    Assess the effect of intravenous human serum albumin ( HSA ) on serum AT ⅱ, VAP , CGRP , ET levels and renal function .

  10. 目的研究对比人血白蛋白及四氯化碳(CCl4)两种制备大鼠肝纤维化模型的差别,为临床实验研究提供参考。

    Objective To investigate and determine the difference of human albumin induced and CCl 4 induced liver fibrosis in rats .

  11. 方法采用以人血白蛋白攻击方法制备肝纤维化动物模型,放免法测定血TNF,免疫组化法观察肝内层粘蛋白改变。

    Methods The rat models of hepatic fibrosis were established by human serum albumin ( HSA ) injection . Serum TNF was detected by RIA method and laminin in the liver was studied by immunohistochemistry .

  12. 从低温乙醇法FIV组份中分离人血白蛋白的研究

    Seperation of Human Albumin from the FIV of the Cold Ethanol Method

  13. 目的探讨人血白蛋白免疫诱导型及四氯化碳(CCl4)毒素诱导型所致大鼠肝纤维化模型肝组织中金属蛋白酶组织抑制因子(TIMP)定位及表达状态的差异。

    Objective To investigate the difference of the location and expression of TIMP-1,2 liver fibrosis model in rats between immune induced and toxin induced .

  14. OP-Ab与相关蛋白及多肽如人血白蛋白、甲状腺素(T3、T4)、胰岛素、胰高血糖素、促甲状腺素及心钠素等无明显交叉反应。

    No cross reaction was found between OP-Ab and related proteins or polypetides . such as human plasma albumin , T3 , T4 , insulin , glucagon , TSH and ANF .

  15. 载人参皂苷Rb1和银耳多糖的人血白蛋白微粒载药量较高,载阿霉素和异硫氰酸荧光素的人血白蛋白微粒载药量较低。

    Ginsenoside Rb1 and Tremella polysaccharides human serum albumin particles have higher drug loading , and adriamycin and fluorescein isothiocyanate human serum albumin particles have lower drug loading .

  16. 介绍了用DTPA(二乙三胺五醋酸)作为双官能团螯合剂与HSA(人血白蛋白)进行偶联,以提高放射性核素标记的HSA的体内稳定性的方法。

    Diethylenetriaminepentaacetic acid ( DTPA ) used as a bifunctional chelator coupling with human serum albumin ( HSA ) to improve the in vivo stability of radionuclides labeled HSA has been studied .

  17. 方法10只荷VX2肝肿瘤新西兰白兔,经耳缘静脉团注人血白蛋白氟碳微泡造影剂,剂量0.04ml/kg;

    Methods 10 New Zealand rabbits bearing hepatic VX_2 tumors were intravenously administered perfluorocarbon filled human albumin microbubbles through ear veins at 0.04 ml / kg when the livers were surgically exposed .

  18. 荧光比色法测定人血白蛋白注射液中利凡诺的残留量

    Fluorometric Determination of Residual Rivanol in The Human Blood Albumin Injection

  19. 重组人血白蛋白与小分子药物结合功能研究

    Binding Function of Recombinant Human Serum Albumin to Small Molecule Drugs

  20. 人血白蛋白热原去除工艺的实验

    Experiment on pyrogen removal process for human plasma albumin production

  21. 人血白蛋白的两种低温乙醇工艺的比较

    Comparison between two low-temperature ethanol processes for human plasma albumin

  22. 甲氨蝶呤人血白蛋白微球制备工艺的优化

    Optimization of Preparation Technique of Methotrexate Human Serum Albumin Microspheres

  23. 人血白蛋白过敏致双侧腮腺肿大

    Enlargement of bilateral parotid glands caused by human serum albumin

  24. 人血白蛋白不良反应分析

    Document analysis of the adverse drug reaction in using Human Serum Albumin

  25. 人血白蛋白中铝离子残留量的测定

    The Measurement of Residual Aluminium Ion in Human Blood Albumin

  26. 人血白蛋白实施国家批签发制度后的质量评价

    Quality Evaluation on Domestic Human Albumin Preparations after Implementation of Lot Release

  27. 人血白蛋白278例临床应用调查与分析

    Analysis of the Clinical Applications of Human Serum Albumin in 278 Inpatients

  28. 光谱法与分子模拟对左旋紫草素和人血白蛋白键合作用的研究

    Study on Shikonin-Human Serum Albumin Interaction by Spectroscopic and Molecular Simulation Methods

  29. 四氯化碳、人血白蛋白所致大鼠肝纤维化动物模型的实验研究

    Experimental Study of CCl_4 and HSA Induced Animal Models of Liver Fibrosis

  30. 全氟丙烷人血白蛋白微球注射液配制方法的优化

    Optimal Formula of Perfluoropropane Microspheres Containing Human Albumin for Injection